Ulrik Mouritzen Selected Research

Ulrik Mouritzen Research Topics

2	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2019 - 01/2018
2	Renal Cell Carcinoma (Grawitz Tumor) 01/2011 - 11/2010
2	Melanoma (Melanoma, Malignant) 11/2010 - 03/2009
1	Inflammation (Inflammations) 01/2022
1	Kidney Diseases (Kidney Disease) 01/2022
1	Fibrosis (Cirrhosis) 03/2021
1	Disease Progression 03/2021
1	Short Bowel Syndrome 01/2019
1	Nausea 01/2019
1	Vomiting 01/2019
1	Infarction (Infarctions) 10/2018
1	ST Elevation Myocardial Infarction 10/2018
1	Myocardial Infarction 10/2018
1	Hypoglycemia (Reactive Hypoglycemia) 01/2018
1	Diabetic Retinopathy (Retinopathy, Diabetic) 01/2018
1	Rheumatoid Arthritis 04/2016
1	Thrombocytopenia (Thrombopenia) 01/2011
1	Neoplasms (Cancer) 01/2011
1	Neutropenia 01/2011
1	Hypersensitivity (Allergy) 11/2010
1	Lethargy 11/2010
1	Hyperbilirubinemia 11/2010
1	Autoimmune Diseases (Autoimmune Disease) 03/2009
1	Osteoarthritis 09/2004
1	Joint Diseases (Joint Disease) 09/2004
1	Type 2 Diabetes Mellitus (MODY) 12/2003

3	Glucagon (Glukagon)FDA Link 01/2019 - 01/2018
3	interleukin-21 (interleukin 21)IBA 01/2011 - 03/2009
2	Blood Glucose (Blood Sugar)IBA 01/2022 - 01/2018
2	Proteins (Proteins, Gene)FDA Link 01/2022 - 03/2021
2	danegaptideIBA 03/2021 - 10/2018
2	dasiglucagonIBA 01/2019 - 01/2018
2	Glucose (Dextrose)FDA LinkGeneric 01/2019 - 01/2018
1	NLR ProteinsIBA 01/2022
1	InflammasomesIBA 01/2022
1	Connexin 43 (Connexin43)IBA 01/2022
1	ConnexinsIBA 01/2022
1	Adenosine Triphosphate (ATP)IBA 03/2021
1	Insulin (Novolin)FDA Link 01/2018
1	Monoclonal AntibodiesIBA 04/2016
1	InterleukinsIBA 04/2016
1	Dihydrotachysterol (AT 10)IBA 01/2011
1	CytokinesIBA 01/2011
1	Sunitinib (Sutent)FDA Link 01/2011
1	Transaminases (Aminotransferases)IBA 11/2010
1	Biological ProductsIBA 03/2009
1	Selective Estrogen Receptor Modulators (SERM)IBA 09/2004
1	Estrogens (Estrogen)FDA Link 09/2004
1	insulin aspart protamine drug combination 30:70 insulin aspartIBA 12/2003
1	Glyburide (Glibenclamide)FDA LinkGeneric 12/2003
1	Rosiglitazone (Avandia)FDA Link 12/2003

1	Percutaneous Coronary Intervention 10/2018
1	Subcutaneous Injections 01/2018
1	Therapeutics 03/2009